Why Monitoring Matters in HGH Therapy

HGH therapy works by restoring growth hormone levels that have declined due to adult growth hormone deficiency (AGHD). Growth hormone affects metabolism, glucose regulation, bone density, cardiovascular function, and muscle mass — making ongoing oversight essential to maximize benefits while avoiding side effects. The goal of monitoring is to keep your IGF-1 levels — the primary blood marker of growth hormone activity — within the optimal range for your age and sex.

Baseline Labs Before You Start

Before your first injection, your Synergya Medical physician will order a comprehensive baseline panel. This typically includes:

• IGF-1 (Insulin-like Growth Factor-1) — the main marker used to guide dosing
• Fasting glucose and HbA1c — to establish a baseline for glucose metabolism
• Fasting lipid panel — total cholesterol, LDL, HDL, and triglycerides
• Liver enzymes (AST, ALT) — to confirm baseline liver health
• Thyroid function (TSH, free T4) — because thyroid and growth hormone interact closely
• Complete blood count and metabolic panel — general health baseline

IGF-1 — The Central Marker of HGH Therapy

IGF-1 is produced in the liver in response to growth hormone signaling. It is the most reliable and practical blood marker for monitoring HGH therapy in adults. Unlike growth hormone itself — which rises and falls in pulses throughout the day — IGF-1 remains relatively stable in the bloodstream. The target range for IGF-1 in adults on HGH therapy is generally the upper half of the normal age- and sex-specific reference range, typically expressed as 0 to +1 standard deviation (SD) from the mean for your age group. Physicians avoid pushing IGF-1 above +2 SD, where the risk of side effects increases.

How Dose Adjustments Work

HGH therapy is initiated at a low dose — typically around 0.1 to 0.3 mg per day — and titrated upward gradually based on your IGF-1 response and how you feel. Dose increases are made in small increments, usually 0.1 to 0.2 mg per day, at intervals of four to eight weeks. Your physician assesses both lab numbers and your clinical response: changes in energy, body composition, sleep quality, and any emerging side effects such as joint stiffness, fluid retention, or changes in blood sugar.

Ongoing Lab Schedule

Once a stable dose is established, most patients follow this monitoring schedule:

• 4 to 6 weeks after starting or changing dose: repeat IGF-1 and glucose
• Every 3 to 6 months in the first year: IGF-1, glucose, HbA1c, and lipids
• Annually: comprehensive metabolic panel, IGF-1, lipids, thyroid, and additional markers based on your personal health profile

Monitoring at Synergya Medical

At Synergya Medical, every patient’s HGH therapy plan includes structured lab check-ins, physician review of results, and clear communication about what the numbers mean. Our A4M-certified physicians use IGF-1 as the cornerstone of dose management while also considering the full clinical picture — body composition, energy, sleep, and metabolic markers. Contact Synergya Medical today to get started with a medically supervised HGH therapy program.